Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1691082 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $48.94 · Day +0.35% · Mkt cap $1.5B · Off 52W high −2.1% · Vol (1Y) 65.0% Price2025-09-11 → 2026-08-19 LBRX close: $17.3 on 2025-09-11 to $48.9 on 2026-08-19. Split-adj closes · 226 of 226 · price returnⓘ At a glance | Short interest14.7% of sh out | | Days to cover12.8d | | 13F net flow (QoQ)+4.16% | | Top-10 13F concentration63.6% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns Total return · from 2025-09-11ⓘ Risk | Ann. volatility (1Y)65.0% | | Ann. volatility (3Y)65.0% | | Sharpe (1Y)2.11 | | Sharpe (3Y)2.11 | | Max drawdown (1Y)−17.1% | | Max drawdown (3Y)−17.1% |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Deep Track Capital, LP | 3.4M | $83M | 11.69% | +0.0% | | BlackRock, Inc. | 2.5M | $61M | 8.62% | +10.4% | | RA CAPITAL MANAGEMENT, L.P. | 2.2M | $54M | 7.70% | +0.0% | | TCG Crossover Management, LLC | 1.8M | $45M | 6.41% | +5.4% | | Commodore Capital LP | 1.5M | $37M | 5.23% | +0.0% | | Caligan Partners LP | 1.4M | $35M | 5.02% | new | | Spruce Street Capital LP | 1.4M | $34M | 4.80% | +36.9% | | JPMORGAN CHASE & CO | 1.4M | $33M | 4.98% | −11.4% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$1.71 | — | — | — | | 2026-03-31 | 2026-05-12 | −$0.67 | — | — | — | | 2025-09-30 | 2025-11-06 | −$0.61 | — | — | — | | 2025-06-30 | — | −$13.58 | — | — | — |
As-reported XBRL · next 2026-11-10 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
